ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2
Henit Yanai, Roger Feakins, Mariangela Allocca, Johan Burisch, Pierre Ellul, Marietta Iacucci, Christian Maaser, Alessandra Zilli, Nina Zidar, Rune Wilkens, Bram Verstockt, Stephan R. Vavricka, Mathieu Uzzan, Jaap Stoker, Martina Scharitzer, David T. Rubin, Francesca Rosini, Jordi Rimola, Patrick van Rheenen, Paula Borralho, Kerri L. Novak, Nurulamin M Noor, Olga Maria Nardone, Cathy Lu, Uri Kopylov, Konstantinos Κarmiris, Isabelle De Kock, Amelia Kellar, Konstantinos Κarmiris, Giovanni Maconi, Federica Furfaro, Emma Flanagan, Ann Driessen, Mallory Chavannes, Dominik Bettenworth, Shomron Ben‐Horin, Gauraang Bhatnagar, Paméla Baldin, Torsten Kucharzik, Stuart A. Taylor
Abstract
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), requires meticulous diagnostic and monitoring protocols to optimize patient outcomes. This document synthesizes key advancements and recommendations for clinical indices, endoscopic scoring, imaging, histological assessment, and tools for evaluating IBD disability. Emphasizing validated, reproducible methods aligns with the ongoing evolution of precision medicine in IBD care, including training. The methodology of the guidelines update process is described in part 1.